Literature DB >> 17300217

Purification and identification of the STAT5 protease in myeloid cells.

Björn Schuster1, Lisa Hendry, Helen Byers, Steven F Lynham, Malcolm A Ward, Susan John.   

Abstract

STAT (signal transducer and activator of transcription) proteins are critical regulators of cytokine-induced cell proliferation, differentiation and survival. STAT functional activity can be variably regulated by post-translational modifications, including phosphorylation, acetylation, methylation and sumoylation. Additionally, limited proteolytic digestion of full-length STAT proteins (STATalpha) generates C-terminally truncated forms (STATgamma) in different cell lineages, which have significantly reduced transcriptional activity due to the lack of the transactivation domain. Previously, it has been shown that STAT5gamma, generated by an unidentified nuclear serine protease, plays an important role in myeloid cell differentiation and is aberrantly expressed in acute myeloid leukaemia. To better understand this regulatory mechanism for STAT5 function, we have purified the STAT5 protease from the immature myeloid cell line 32D and identified it by MS analysis as the granule-derived serine protease, CatG (cathepsin G). We show that purified CatG can specifically cleave full-length STAT5 to generate STAT5gamma, and this activity can be inhibited by AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride] in an in vitro protease assay. Importantly, preparation of nuclear and cytoplasmic extracts from immature myeloid cell lines, 32D and FDC-P1, in the presence of a specific inhibitor for CatG results in the identification of STAT5alpha only. These studies indicate that nuclear STAT5gamma does not naturally exist in immature myeloid cells and is artificially generated from STAT5alpha during the preparation of extracts due to the abundance of CatG in these cells. Therefore in contrast with earlier studies, our data suggest that STAT5alpha, rather than STAT5gamma is the active form in immature myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300217      PMCID: PMC1868840          DOI: 10.1042/BJ20061877

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 2.  Neutrophil serine proteases: potential key regulators of cell signalling during inflammation.

Authors:  O Wiedow; U Meyer-Hoffert
Journal:  J Intern Med       Date:  2005-04       Impact factor: 8.989

3.  Stat5a/b are essential for normal lymphoid development and differentiation.

Authors:  Zhengju Yao; Yongzhi Cui; Wendy T Watford; Jay H Bream; Kunihiro Yamaoka; Bruce D Hissong; Denise Li; Scott K Durum; Qiong Jiang; Avinash Bhandoola; Lothar Hennighausen; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

4.  STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells.

Authors:  Jonathan W Snow; Ninan Abraham; Melissa C Ma; Nancy W Abbey; Brian Herndier; Mark A Goldsmith
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts.

Authors:  Z Xia; R R Salzler; D P Kunz; M R Baer; L Kazim; H Baumann; M Wetzler
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Activation of a functionally distinct 80-kDa STAT5 isoform by IL-5 and GM-CSF in human eosinophils and neutrophils.

Authors:  E Caldenhoven; T B van Dijk; J A Raaijmakers; J W Lammers; L Koenderman; R P de Groot
Journal:  Mol Cell Biol Res Commun       Date:  1999-05

7.  The human brm protein is cleaved during apoptosis: the role of cathepsin G.

Authors:  J R Biggs; J Yang; U Gullberg; C Muchardt; M Yaniv; A S Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

8.  Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.

Authors:  Z Xia; S N Sait; M R Baer; M Barcos; K A Donohue; D Lawrence; L A Ford; A M Block; H Baumann; M Wetzler
Journal:  Leuk Res       Date:  2001-06       Impact factor: 3.156

9.  Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation.

Authors:  Andrea Hoelbl; Boris Kovacic; Marc A Kerenyi; Olivia Simma; Wolfgang Warsch; Yongzhi Cui; Hartmut Beug; Lothar Hennighausen; Richard Moriggl; Veronika Sexl
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

10.  Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.

Authors:  Kotaro Suzuki; Hiroshi Nakajima; Shin-Ichiro Kagami; Akira Suto; Kei Ikeda; Koichi Hirose; Takaki Hiwasa; Kiyoshi Takeda; Yasushi Saito; Shizuo Akira; Itsuo Iwamoto
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Targeting signal transducer and activator of transcription signaling pathway in leukemias.

Authors:  Mustafa Benekli; Heinz Baumann; Meir Wetzler
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

2.  N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.

Authors:  Ayush Dagvadorj; Shyh-Han Tan; Zhiyong Liao; Jianwu Xie; Martti Nurmi; Kalle Alanen; Hallgeir Rui; Tuomas Mirtti; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2010-09-18       Impact factor: 5.085

3.  GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.

Authors:  F Seydel; E Garrigan; B Stutevoss; N Belkin; B Makadia; J Carter; J-D Shi; A Davoodi-Semiromi; M McDuffie; S A Litherland
Journal:  J Autoimmun       Date:  2008-10-21       Impact factor: 7.094

4.  STAT5 isoforms: controversies and clarifications.

Authors:  Haydeé L Ramos; John J O'Shea; Wendy T Watford
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

5.  Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1.

Authors:  Leo Edlinger; Angelika Berger-Becvar; Ingeborg Menzl; Gregor Hoermann; Georg Greiner; Eva Grundschober; Zsuzsanna Bago-Horvath; Wael Al-Zoughbi; Gerald Hoefler; Christine Brostjan; Lars Gille; Richard Moriggl; Andreas Spittler; Veronika Sexl; Andrea Hoelbl-Kovacic
Journal:  Br J Haematol       Date:  2017-07-14       Impact factor: 6.998

6.  PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis.

Authors:  A Berger; A Hoelbl-Kovacic; J Bourgeais; L Hoefling; W Warsch; E Grundschober; I Z Uras; I Menzl; E M Putz; G Hoermann; C Schuster; S Fajmann; E Leitner; S Kubicek; R Moriggl; F Gouilleux; V Sexl
Journal:  Leukemia       Date:  2013-11-22       Impact factor: 11.528

7.  A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.

Authors:  K Kollmann; W Warsch; C Gonzalez-Arias; F L Nice; E Avezov; J Milburn; J Li; D Dimitropoulou; S Biddie; M Wang; E Poynton; M Colzani; M R Tijssen; S Anand; U McDermott; B Huntly; T Green
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

Review 8.  ABPP and Host-Virus Interactions.

Authors:  Geneviève F Desrochers; John Paul Pezacki
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

9.  Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Authors:  Caroline Schoenherr; Katharina Wohlan; Iris Dallmann; Andreas Pich; Jan Hegermann; Arnold Ganser; Denise Hilfiker-Kleiner; Olaf Heidenreich; Michaela Scherr; Matthias Eder
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.